In the USA, the quality of generic drugs is in the headlines again following a recent report by investigative journalists at ProPublica. They tested a total of 11 samples spread over three active ingredients, and found that two did not meet quality standards. In reporting their results, they gave figures for the amount of active quality surveillance conducted by the Mighty FDA. In a country with close to 350 million people, a country that spends over US$12,000 a year per…